#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital pseudarthrosis Metastatic malignant melanoma Angiosarcoma recurrent Thromboangiitis obliterans Homocystinuria Uveitis Astrocytoma Angiosarcoma non-metastatic Mixed-type liposarcoma Ichthyosis Glomerulonephritis acute Obliterative bronchiolitis Behcet's syndrome Chemical burn Necrotising myositis More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome – Life with Disease Anaplastic thyroid cancer Proteus syndrome Leiomyosarcoma recurrent – Basic Information Systemic sclerosis pulmonary – Treatment Chronic granulomatous disease – Basic Information Synovial sarcoma – Trials in Disease SAPHO syndrome – Basic Information Haemophilia – Treatment Cystic fibrosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ripretinib Octocog Alfa Tetracaine Hydrochloride Evx-01 Retinol Acetate Viltolarsen Sargramostim Exenatide Ag-946 Ritonavir Tafasitamab Sodium Hypochlorite Betamethasone Dipropionate Rbp030.2 Norepinephrine Colesevelam Sertraline Metformin Indacaterol Apitegromab More therapies…

    Learn about Your Condition

    Psychological trauma Skin angiosarcoma Retinal neovascularisation Immunosuppression Giant cell arteritis Anal abscess Cardiac failure chronic Cutaneous sarcoidosis Iron overload Carotid artery stenosis Alcohol abuse Pancreatic carcinoma Labour pain Vaginal infection Coagulopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Parkinson’s disease

  • Study on Donepezil for Mild Cognitive Impairment in Parkinson’s Disease Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Donepezil Hydrochloride
    Spain

  • Study on Safinamide and Rasagiline for Treating Fatigue in Parkinson’s Disease Patients on Stable Dopaminergic Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic fatigue syndrome
    • Parkinson’s disease
    Investigated Drugs:
    • Rasagiline
    • Safinamide
    Spain

  • Study on Montelukast for Slowing Parkinson’s Disease Progression in Patients with Mild to Moderate Symptoms

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Benserazide Hydrochloride
    • Levodopa
    • Montelukast Sodium
    Sweden

  • Study on the Safety and Effects of ACI-7104.056 in Patients with Early Parkinson’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Ioflupane (123I)
    • Pd01B
    Germany Spain

  • Study on Pain in Parkinson’s Disease: Examining the Effects of 18F-MPPF in Patients with and without Pain

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • 4-Fluoro-N-[2-[4-(2-Methoxyphenyl)Piperazin-1-Yl]Ethyl]-N-Pyridin-2-Ylbenzamide
    France

  • Study of inhaled levodopa versus oral levodopa plus benserazide for early‑morning OFF in Parkinson’s disease patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Benserazide Hydrochloride
    • Levodopa
    Denmark
Previous Page
1 2 3 4 5 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!